Morgan Stanley Oracle · ORCL

Morgan Stanley Lowers Oracle Price Target to $207

Analyst: Keith Weiss 1 min read Reproduced verbatim
Rating
Unknown
Target
$207
from $213 (−3%)
Outcome
Reached
on May 29, 2026
Morgan Stanley and Oracle logos

What the analyst said

Morgan Stanley analyst Keith Weiss lowered the price target on Oracle (NYSE: ORCL) to $207.00 (from $213.00) while maintaining an Equalweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $116. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $207 target is 11% below the median.

Since the note ORCL has moved −38% (from $188). 12-month window: day 197 of 365, closes on April 23, 2027.

Track record

This call✓ Target reached on May 29, 2026, 36 days after the note.

Firm track recordMorgan Stanley: 82% of its 50 targets at least a year old were reached within 12 months (#8 of 26 firms). Accuracy ranking →

Morgan Stanley on Oracle

Morgan Stanley price targets on Oracle

4 calls from January 23, 2026 to September 4, 2026. The target went from $213 to $210 (−1%). The rating stayed Hold.

Morgan Stanley targetORCL share price
  1. September 4, 2026Target raised from $207 (+1%)Hold$210
  2. June 11, 2026Kept the $207 targetHold$207
  3. April 23, 2026 This noteTarget cut from $213 (−3%)$207
  4. January 23, 2026Earliest call shown$213
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.